Joanne Billings, MD

Current Position:  Assistant Professor of Medicine, University of Minnesota

T32 Support:  1997 - 2000

Education:     1984 – 1988, B.S., Illinois Benedictine
                        College
                      1988 – 1992, M.D. Rush Medical College
                      1992 – 1995, Internal Medicine Residency,
                        University of Minnesota
                      1995 – 1996, Chief Resident, VA Medical
                        Center, Minneapolis, MN
                      1996 – 2000, Pulmonary/Critical Care
                         Fellow, Univ. of MN

Project:            Completed the coursework for an MPH with a major in epidemiology during my time on this T32.  I completed my master’s thesis on lung function as a predictor of mortality outcomes in the Multiple Risk Factor Intervention Trial participants.  I had the opportunity to work with well-established epidemiologists and biostaticians during my research.

Master’s Thesis:  “Lung Function and Mortality in the Multiple Risk Factor Intervention Trial (MRFIT)” under the mentorship of Dr. John E. Connett.

Field Instruction in Epidemiology:  work in Department of Epidemiology with Drs. Folsom and Shahar on the analysis, interpretation and preparation of manuscript for “Pulmonary Function and Incident Ischemic Stroke: the Atherosclerosis and Risk in Communities (ARIC) Study”

Grants Awarded:            NIH K23 Award (currently in no-cost extension)
                                       Cystic Fibrosis Foundation Scholar Award
                                       Cystic Fibrosis Foundation Therapeutic Development
                                            Network (site PI)

Publications:

Rubins JB, Bofenkamp C, Youngblood M, Billings J, Broccard A.  Premedication with ipratropium bromide for bronchoscopy produces subjective discomfort without significant clinical benefit.  Journal of Bronchology.     1998; 5:200-203.

Billings JL, Dunitz JM, Warwick WJ, Milla CE.  Long-term survival of women with cystic fibrosis following pregnancy.  Presentation at 2000 North American Cystic Fibrosis Conference.

Dunitz JD, Billings JL, Savik SK, Moran AM.  Pre-transplant diabetes mellitus does not adversely impact short or long term outcomes in patients undergoing lung transplantation for cystic fibrosis.  Pediatric Pulmonology 2001; S22: 428.

Billings JL, Hertz MI, Wendt CH.  Community respiratory virus infections following lung transplantation.  Transplant Infectious Disease     2001; 3(3):138-48.

Billings JL, Hertz MI, Savik K, Wendt CH.  Respiratory viruses and chronic rejection in lung transplant recipients.  Journal of Heart and Lung Transplantation    2002; 21(5):559-66.

Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.  Diabetes Care 2005; 28(9):2141-4.

Weinert CR, Billings J, Ryan R, Ingbar DH, Academic and career development of pulmonary and critical care physician-scientists.  American Journal of Respiratory & Critical Care Medicine 2006; 173(1):23-31.

Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR.  Lung function and ischemic stroke incidence:  The Atherosclerosis Risk in Communities Study.  Chest  2006; 130(6): 1642-9.

Kempainen RR, Savik K, Whelan TP. Dunitz JM, Herrington CS, Billings JL.  High prevalance of proximal and distal gastroesophageal reflux disease in advanced COPD.  Chest  2007; 131(6):1666-71.